Plain-English translation of NCT07258914 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing repetitive transcranial magnetic stimulation (rTMS) — a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain — for people with autism who are struggling with depression. While this treatment is already used in regular medical practice for depression in non-autistic patients, very little research has been done on how well it works for autistic people. This study wants to find out if it is both safe and effective for this group.
Depression is much more common in autistic people than in the general population, but current treatments — especially medications — don't work well for many autistic individuals. Doctors need better options for treating depression in autism, and early research suggests this brain stimulation technique might help.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive brain stimulation treatment sessions. Each day, you will have 4 short sessions of 10 minutes each, with breaks of about 50 minutes between them. The exact number of treatment days and duration of the overall study will be explained to you in detail before you start. Before and after the treatment, your depression symptoms — including irritability — will be carefully measured to see if the treatment helped.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
France